Skip to main content
. 2021 Mar 15;29(2):343–366. doi: 10.1007/s10787-021-00796-w

Table 2.

A few known kinase inhibitors

Drug candidate Molecular target
Baricitinib JAK1/2/3
BMS-986165 Tyk2
Decernotinib JAK-3
Delgocitinib pan inhibitor of JAKs
Fedratinib JAK-2
Filgotinib JAK-1
Itacitinib JAK-1
NDI-031232 Tyk2
NDI-031407 Tyk2
Olacitinib JAK1/2/3
Peficitinib JAK-1/2/3
PF-06651600 JAK-3
PF-06826647 Tyk2/JAK-1/2
Ruxolitinib JAK1/2
SAR-20347 Tyk2/JAK-1/2/3
Solcitinib JAK-1
Tofacitinib JAK1/3
Upadacitinib JAK-1